Literature DB >> 7507139

Some ascites monoclonal antibody preparations contain contaminants that bind to selected Golgi zones or mast cells.

S S Spicer1, M A Spivey, M Ito, B A Schulte.   

Abstract

A small proportion of mouse ascites fluid induced by hybridomas producing monoclonal antibodies or myelomas secreting immunoglobulin yielded staining that was confined to the Golgi zone of certain epithelial cell types in rats and gerbils but not in mice. In addition, a commercial IgG fraction from mouse plasma similarly labeled the Golgi area, unlike IgG from mouse serum from another source. Culture supernatant from one hybridoma line contrasted with ascites fluid produced by the same hybridoma in failing to stain the Golgi region. The capacity of a fluid to react with the Golgi cisternae bore no relationship to the class of immunoglobulin secreted by the hybridoma or myeloma. Absorption of an ascites fluid with blood group A1 human erythrocytes eliminated its affinity for Golgi cisternae. Adsorption with blood group A2 or B or two type O cells used for screening for blood group antibodies had no effect on Golgi zone labeling by this ascites fluid. The positive cells included most serous secretory cells in rats, serous cells of sublingual and tracheal glands, and some endometrial and oviduct-lining cells in gerbils, and columnar lining cells of small intestine and cecum and all or part of the lining cells in some prostate lobes in both genera. Some of the tested ascites fluids stained mast cells. The agent accounting for mast cell labeling differed, however, from that reacting with Golgi cisternae in its distribution among the mouse ascites fluids examined, lack of relationship to the ABO blood group system, occurrence additionally in normal rat serum, and capacity to stain cells in mice as well as rats and gerbils.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507139     DOI: 10.1177/42.2.7507139

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  10 in total

1.  Selection of recombinant anti-SH3 domain antibodies by high-throughput phage display.

Authors:  Haiming Huang; Nicolas O Economopoulos; Bernard A Liu; Andrea Uetrecht; Jun Gu; Nick Jarvik; Vincent Nadeem; Tony Pawson; Jason Moffat; Shane Miersch; Sachdev S Sidhu
Journal:  Protein Sci       Date:  2015-09-16       Impact factor: 6.725

Review 2.  Antibody validation.

Authors:  Jennifer Bordeaux; Allison Welsh; Seema Agarwal; Elizabeth Killiam; Maria Baquero; Jason Hanna; Valsamo Anagnostou; David Rimm
Journal:  Biotechniques       Date:  2010-03       Impact factor: 1.993

3.  Apparent expression of varicella-zoster virus proteins in latency resulting from reactivity of murine and rabbit antibodies with human blood group a determinants in sensory neurons.

Authors:  Leigh Zerboni; Raymond A Sobel; Michelle Lai; Richard Triglia; Megan Steain; Allison Abendroth; Ann Arvin
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel.

Authors:  Emina E Torlakovic; Glenn Francis; John Garratt; Blake Gilks; Elizabeth Hyjek; Merdol Ibrahim; Rodney Miller; Søren Nielsen; Eugen B Petcu; Paul E Swanson; Clive R Taylor; Mogens Vyberg
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-04

5.  Nitric oxide synthase is localized predominantly in the Golgi apparatus and cytoplasmic vesicles of vascular endothelial cells.

Authors:  A J O'Brien; H M Young; J M Povey; J B Furness
Journal:  Histochem Cell Biol       Date:  1995-03       Impact factor: 4.304

6.  Protein kinase C-beta II (PKC-beta II) expression in patients with colorectal cancer.

Authors:  Karen-Lise Garm Spindler; Jan Lindebjerg; Michael Lahn; Sanne Kjaer-Frifeldt; Anders Jakobsen
Journal:  Int J Colorectal Dis       Date:  2009-03-10       Impact factor: 2.571

7.  Presence of a neo-epitope and absence of amyloid beta and tau protein in degenerative hippocampal granules of aged mice.

Authors:  Gemma Manich; Jaume del Valle; Itsaso Cabezón; Antoni Camins; Mercè Pallàs; Carme Pelegrí; Jordi Vilaplana
Journal:  Age (Dordr)       Date:  2013-07-19

8.  Beyond natural antibodies: the power of in vitro display technologies.

Authors:  Andrew R M Bradbury; Sachdev Sidhu; Stefan Dübel; John McCafferty
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908

Review 9.  Anything You Can Do, I Can Do Better: Can Aptamers Replace Antibodies in Clinical Diagnostic Applications?

Authors:  Michelle Bauer; Mia Strom; David S Hammond; Sarah Shigdar
Journal:  Molecules       Date:  2019-11-30       Impact factor: 4.411

Review 10.  The Evolution of Molecular Recognition: From Antibodies to Molecularly Imprinted Polymers (MIPs) as Artificial Counterpart.

Authors:  Ortensia Ilaria Parisi; Fabrizio Francomano; Marco Dattilo; Francesco Patitucci; Sabrina Prete; Fabio Amone; Francesco Puoci
Journal:  J Funct Biomater       Date:  2022-01-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.